PROK · ProKidney Corp. Class A Ordinary Shares

NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD

Prokidney Corp (PROK)

NASDAQ NMS - GLOBAL MARKET Biotechnology
Move probability → Options chain →
$1.45 +0.00 (+0.35%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE $1.45
$1.44 $1.49
52-WEEK RANGE $1.45
$1.30 $3.48

What's happening

Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.

Key Statistics

Market Cap$439.9M
P/E (TTM1)—
EPS2 (TTM)$-0.55
Div Yield—
Beta31.95
Volume45,912
Open1.44
Prev Close1.45
Bid / Ask1.22 / 0.00
Next Earnings 2026-11-09

Analyst Recommendations

Strong buy 5 Buy 4 Hold 4 Sell 1 Strong sell 0

Aggregate ratings for 2026-10-01 (14 analysts polled by Finnhub) — consensus count.

Performance Overview (Trailing returns vs S&P 500 benchmark)

YTD RETURN
PROK -35.71%
vs S&P 500 -48.49%
1-YEAR RETURN
PROK -56.23%
vs S&P 500 -70.79%
6-MONTH RETURN
PROK -26.15%
3-MONTH RETURN
PROK -9.72%

Valuation Measures & Ratios

Enterprise Value4$360.5M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)532.21
Price / Book7322.02
EV4 / Revenue440.76
EV4 / EBITDA—
Profit Margin-10288.39%
Operating Margin-21664.55%
Return on Equity (ROE8)-28.10%
Return on Assets (ROA9)-27.39%
Avg Volume (3M)1,362,180
Glossary — what these abbreviations mean
1. TTM
Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
2. EPS
Earnings per share — net income divided by diluted shares outstanding.
3. Beta
A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
4. EV (Enterprise Value)
Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
5. Forward P/E
Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
6. PEG Ratio
P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
7. Price / Book
Share price divided by book value (assets minus liabilities) per share.
8. ROE
Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
9. ROA
Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
10. MRQ
Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
11. YoY
Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.

Short Interest

Shares Short23,785,320
Change from Prior Settlement+10.91%
% of Float—
Days to Cover (Short Ratio)10.97

Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.

Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.

Price history

Events

Drag horizontally to zoom into a section; use Reset view to restore all observations.

Technical signal summary

Calculating from the latest year of daily price history…

Calculating…
Show Technical Analysis Breakdown ▾ 10 Indicators

Not investment advice — read several signals together.

Indicators None active

Add lines over the price chart or a panel below it. Your choices are saved on this device.

Starter sets
Trend
Oscillators
Volume/volatility
Loading chart…

History limited by data provider; markers are heuristics, not signals.

Peer and sector context

No reviewed peer group is available for this symbol.

Balanced evidence

A deterministic summary of sourced facts—not an AI verdict.

Potential strengths

  • Latest SEC filing is Form 4, filed 2026-08-20; review it for current changes and risks. SEC EDGAR ↗

Potential concerns

Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.

Financials

Income statement

Line item Jun '26Mar '26Sep '25Jun '25Mar '25Sep '24Jun '24Mar '24
Operating income -$48.4M -$44.9M -$38.5M -$39.7M -$41.4M -$49.0M -$43.1M -$40.1M
Net income -$28.4M -$20.0M -$16.5M -$16.6M -$16.7M -$17.9M -$12.5M -$9.5M

Balance sheet

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Total assets $249.0M $292.8M $335.6M $351.6M $372.1M $406.1M $441.1M $474.8M
Total liabilities $26.2M $29.7M $34.8M $33.3M $32.7M $36.1M $39.4M $31.3M
Stockholders' equity -$883.5M -$1.02B -$1.01B -$1.01B -$1.00B -$998.6M -$995.0M -$979.7M
Total current assets $189.8M $234.9M $280.7M $300.0M $324.4M $359.7M $395.9M $430.2M
Total current liabilities $22.7M $25.9M $30.7M $29.1M $28.3M $32.8M $36.2M $25.2M
Cash & equivalents $74.9M $101.9M $108.5M $95.3M $84.9M $97.8M $99.1M $108.1M

Cash flow

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Operating cash flow -$40.4M -$41.7M -$32.5M -$26.6M -$31.4M -$29.6M -$24.2M -$29.2M
Investing cash flow $12.8M $34.8M $28.1M $29.0M $18.6M $28.3M $15.1M -$81.6M
Financing cash flow $541.0K $215.0K $17.6M $8.0M -$14.0K -$12.0K $123.0K $4.5M
Free cash flow -$44.2M -$45.5M -$38.3M -$31.8M -$34.5M -$30.7M -$49.7M -$31.6M
Capital expenditures $3.8M $3.8M $5.8M $5.2M $3.1M $1.1M $25.5M $2.4M
Depreciation & amortization $1.7M $1.7M $1.8M $1.7M $1.5M $1.6M $1.6M $1.5M

Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.

Institutional holders

SEC Form 13F filers holding PROK as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.

Institutional ownership is not available for this symbol right now.

Insider activity

Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-06-03 to 2026-08-20

Recent transactions

  • Insiders have net sold 757,164 shares over the last 182 days, across 0 purchases and 6 sales.
  • Most recent: Pereira Brian JG (Reporting person) — Open market sale of 222,948 shares on 2026-08-20.

Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.

Insider purchases & sales, last 6 months

Purchases (open market)0 sh(0 txns)
Sales (open market)757,164 sh(6 txns)
Net Shares-757,164

Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.

Insider roster

NameTitleMost Recent TransactionDateShares
Pereira Brian JGReporting personOpen market sale2026-08-20222,948
Girolamo Todd CChief Legal OfficerDerivative conversion2026-06-12163,857
Control Empresarial de Capitales S.A. de C.V.Reporting personDerivative conversion2026-04-2863,118,645
Weber Darin J.Chief Regulatory OfficerOpen market sale2025-07-08103,480
Legorreta Pablo G.Reporting personDerivative conversion2025-06-033,823,996

Recent transactions

DateInsiderTitleTransactionSharesPrice
2026-08-20Pereira Brian JGReporting personOpen market sale 222,948$1.42
2026-08-20Pereira Brian JGReporting personOpen market sale 27,052$1.42
2026-08-19Pereira Brian JGReporting personOpen market sale 222,949$1.44
2026-08-19Pereira Brian JGReporting personOpen market sale 27,051$1.44
2026-08-18Pereira Brian JGReporting personOpen market sale 229,338$1.37
2026-08-18Pereira Brian JGReporting personOpen market sale 27,826$1.37
2026-08-04Pereira Brian JGReporting personDerivative conversion 81,929$0.00
2026-08-04Pereira Brian JGReporting personDerivative conversion 675,235$0.00
2026-06-12Girolamo Todd CChief Legal OfficerDerivative conversion 163,857$0.00
2026-04-28Control Empresarial de Capitales S.A. de C.V.Reporting personDerivative conversion 63,118,645$0.00
2025-11-13Pereira Brian JGReporting personOpen market sale 447,803$2.37
2025-11-13Pereira Brian JGReporting personOpen market sale 54,333$2.37
2025-11-12Pereira Brian JGReporting personOpen market sale 227,431$2.72
2025-11-12Pereira Brian JGReporting personOpen market sale 27,595$2.72
2025-07-08Weber Darin J.Chief Regulatory OfficerOpen market sale 103,480$3.02
2025-06-03Legorreta Pablo G.Reporting personDerivative conversion 3,823,996$0.00
2025-06-03Legorreta Pablo G.Reporting personOther acquisition/disposition 3,823,996$0.00

Recent SEC filings

Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR submissions · updated 2026-10-21 23:25 UTC

FiledFormReport periodOfficial filing
2026-08-2042026-08-18 View on SEC.gov →
2026-08-108-K2026-08-10 View on SEC.gov →
2026-08-1010-Q2026-06-30 View on SEC.gov →
2026-08-0642026-08-04 View on SEC.gov →
2026-07-0642026-07-01 View on SEC.gov →
2026-06-1542026-06-12 View on SEC.gov →
2026-05-2942026-05-28 View on SEC.gov →
2026-05-2942026-05-28 View on SEC.gov →
2026-05-2942026-05-28 View on SEC.gov →
2026-05-2942026-05-28 View on SEC.gov →
2026-05-2942026-05-28 View on SEC.gov →
2026-05-2942026-05-28 View on SEC.gov →

Headlines about PROK (ProKidney Corp. Class A Ordinary Shares). Links open the publisher — we don’t host full articles.

SEC filings ↓

← Back to the full dashboard · My watchlist